Home › HIV
HIV clinical trials recruiting in the U.S.
137 studies for HIV are recruiting participants at sites across the United States.
HIV (human immunodeficiency virus) attacks the body’s immune system. There is no cure but it can be treated with medicines. To know if you have HIV, get tested.
Cities with the most studies
- Washington, DC22 studies
- New York City, NY18 studies
- Miami, FL17 studies
- Houston, TX17 studies
- Baltimore, MD16 studies
- San Francisco, CA15 studies
- Chicago, IL14 studies
- Atlanta, GA14 studies
- Philadelphia, PA11 studies
- Boston, MA11 studies
- San Diego, CA10 studies
- Los Angeles, CA9 studies
- Seattle, WA8 studies
- Columbus, OH7 studies
- New Haven, CT7 studies
- Orlando, FL7 studies
- Dallas, TX7 studies
- Birmingham, AL7 studies
- West Palm Beach, FL6 studies
- Durham, NC6 studies
- Salt Lake City, UT5 studies
- Winston-Salem, NC5 studies
- The Bronx, NY5 studies
- Port Saint Lucie, FL5 studies
- Kansas City, MO5 studies
- Tampa, FL5 studies
- Aurora, CO5 studies
- Newark, NJ5 studies
- New Orleans, LA5 studies
- Greensboro, NC4 studies
- Jacksonville, FL4 studies
- Las Vegas, NV4 studies
- Cincinnati, OH4 studies
- St. Louis, MO4 studies
- Burbank, CA4 studies
- Nashville, TN4 studies
- Miami Gardens, FL3 studies
- Pittsburgh, PA3 studies
- Minneapolis, MN3 studies
- Memphis, TN3 studies
By state
- Alabama9 studies
- California33 studies
- Colorado7 studies
- Connecticut8 studies
- District of Columbia9 studies
- Florida26 studies
- Georgia14 studies
- Illinois14 studies
- Kentucky3 studies
- Louisiana6 studies
- Maryland29 studies
- Massachusetts12 studies
- Michigan4 studies
- Minnesota3 studies
- Missouri8 studies
- Nevada4 studies
- New Jersey6 studies
- New York22 studies
- North Carolina13 studies
- Ohio10 studies
- Pennsylvania11 studies
- Tennessee7 studies
- Texas23 studies
- Utah5 studies
- Virginia4 studies
- Washington8 studies
Recently updated studies
Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT03300830Viral Load in Blood and Lymph Tissues in People Living With HIV
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 100 · All sexes · Updated Sep 28, 2026 · NCT00001316Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
RecruitingObservational study
Ages 18 to 120 · All sexes · Updated Sep 28, 2026 · NCT00006518Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Antiretroviral Naive HIV-1 Research Participants
RecruitingObservational study
Ages 18 to 120 · All sexes · Updated Sep 28, 2026 · NCT00039689A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 28, 2026 · NCT07650916HIV and Alcohol Research Center Focused on Polypharmacy (HARP) Pilot 2 (2nd HARP Pilot Intervention)
RecruitingPhase 1
Ages 50 and older · All sexes · Updated Sep 25, 2026 · NCT06513819El Camino HIV Prevention and Care Study
Recruiting
Ages 18 and older · Men · Updated Sep 22, 2026 · NCT07834853Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...
RecruitingPhase 1/2Healthy volunteers welcome
Ages 12 to 120 · All sexes · Updated Sep 22, 2026 · NCT05470491Leukapheresis to Obtain Plasma or Lymphocytes for Studies of HIV-infected Patients, Including Long-term Non-progressors
RecruitingObservational study
Ages 18 to 100 · All sexes · Updated Sep 22, 2026 · NCT00029445ADELANTE: A Randomized Controlled Trial to Improve Engagement in Care for Latinos With HIV
Recruiting
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06274632Imaging and Biopsy of People With HIV-1 Undergoing Analytic Treatment Interruption
RecruitingPhase 2
Ages 18 to 100 · All sexes · Updated Sep 22, 2026 · NCT05419024A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT07266831A Seek, Test, and Treat Intervention to Reduce Chlamydia Trachomatis Disparities
RecruitingHealthy volunteers welcome
Ages 15 to 26 · All sexes · Updated Sep 21, 2026 · NCT06428643The TAIL-PrEP Study
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT06868641Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 60 · All sexes · Updated Sep 18, 2026 · NCT06665646Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV
RecruitingPhase 1
Ages 18 to 99 · All sexes · Updated Sep 17, 2026 · NCT04902443Couples Motivational Interviewing to Reduce Drug Use and HIV Risk in Vulnerable Male Couples
RecruitingHealthy volunteers welcome
Ages 18 to 55 · Men · Updated Sep 17, 2026 · NCT06307977A Remotely Delivered Tai Chi/Qigong Intervention for Older People Living With HIV
Recruiting
Ages 50 to 75 · All sexes · Updated Sep 16, 2026 · NCT06586619Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT07473778Observational Pharmaco-Epidemiology Research & Analysis
RecruitingObservational studyHealthy volunteers welcome
Ages 0 and older · All sexes · Updated Sep 11, 2026 · NCT03813862PRIDE III Prison Interventions and HIV Prevention Collaboration
Recruiting
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT06962033Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
RecruitingPhase 1/2
48 Hours · All sexes · Updated Sep 9, 2026 · NCT02140255Development and Evaluation of a Virtual Reality Tool for At-Risk Trauma-Exposed Young People
RecruitingHealthy volunteers welcome
Ages 15 to 30 · All sexes · Updated Sep 9, 2026 · NCT05816083SCOPE: Observational Study of the Consequences of the Protease Inhibitor Era
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT00187512Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus
RecruitingPhase 2
All ages · All sexes · Updated Sep 4, 2026 · NCT02479698From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.